首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
METHOD OF PRODUCING ALKALINE METAL THERMOPHOSPHATES
摘要
申请公布号
SU833155(A3)
申请公布日期
1981.05.23
申请号
SU19782584548
申请日期
1978.02.27
申请人
KALI-KHEMI (FIRMA)
发明人
ULRIKH KHAUSHILD,DE;KHANS-KHAJNTS KASPERS,DE;KHAJNRIKH RETGER,DE
分类号
C05B13/02;(IPC1-7):C05B13/02
主分类号
C05B13/02
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Financial products having demand-based, adjustable returns, and trading exchange therefor
Phenolic coated refractory aggregates
Mutations of the HFE gene associated with iron disorders such as hemochromatosis
PROCESSO PARA O FABRICO DE UM MEDICAMENTO CONTENDO PLASMOPROTEINA
A hydronaphtalene ring compound, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
Method of treating addictive behaviour by administering a GVG drug also known as the epileptic vigabatrin (sabril)
Apparatus and methods for tendon or ligament repair
A method and an arrangement for handling of information regarding economic events
Portable spray device with vertical or horizontal spray direction in normal orientation
Regulated expression of cytokinin modulating genes in plant seeds
Automated transcription system and method using two speech converting instances and computer-assisted correction
Method of modulating metabolite biosynthesis in recombinant cells using an AP2-domain transcription factor that is involved in the response of a plant cell to a jasmonate
Transgenic bovine that produce the heterologous protein in milk
1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders
Method of performing transgenesis
Nucleic acid constructs comprising a hepatitis B core antigen and a cytolytic T lymphocyte antigen for genetic immunization
Oral delivery of antioxidants vitamin C and vitamin E combinations in slow- and plain-release formulations for treating oxidative stress
Energy-activated compositions for controlled sustained release of a gas
Phenol/formaldehyde and polyacrylic acid co-binder and low emissions process for making the same
Tricyclic benzodiazepines as vasopressin receptor antagonists